Hannah Heiligman
Physician Assistant · San Antonio, TXNPI 1902438955
Payments from drug & device makers
Across 288 payments — averaging $20.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- Amgen$1K
- Lilly USA, LLC$656
- AbbVie$406
- AstraZeneca$271
- GSK$240
- plus $2K from 26 others
What the payments were for
- Food & beverage$5,71699%
- Education$611%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 66 | $1,528 |
| Amgen | 52 | $1,088 |
| Lilly USA, LLC | 35 | $656 |
| AbbVie | 21 | $406 |
| AstraZeneca | 14 | $271 |
| GSK | 13 | $240 |
| Pfizer | 13 | $232 |
| Sumitomo Pharma America, Inc. | 10 | $196 |
| Merck | 9 | $169 |
| Astellas Pharma US Inc | 5 | $129 |
| Johnson & Johnson | 4 | $88 |
| Idorsia Pharmaceuticals US Inc | 5 | $84 |
| Bayer | 4 | $76 |
| Exact Sciences | 4 | $67 |
| Sunovion Pharmaceuticals Inc. | 4 | $62 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $60 |
| Phathom Pharmaceuticals, Inc. | 3 | $55 |
| Nestle Healthcare Nutrition Inc. | 3 | $55 |
| Boehringer Ingelheim | 2 | $38 |
| Corcept Therapeutics | 2 | $37 |
| Esperion Therapeutics, Inc. | 2 | $31 |
| Ascend Therapeutics US, LLC | 2 | $28 |
| Smith+Nephew | 2 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Amarin Pharma, Inc. | 1 | $22 |
| Bausch Health US, LLC | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Novartis | 1 | $16 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| Dexcom, Inc. | 1 | $13 |
| Lupin Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,777 in reported general payments places this provider in the 90th percentile of 8,308 physician assistant providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 104 | $155,548 |
| OzempicSemaglutide | 105 | $138,534 |
| TrulicityDulaglutide | 44 | $95,195 |
| ForteoTeriparatide | 11 | $45,158 |
| MounjaroTirzepatide | 27 | $37,446 |
| ProliaDenosumab | 18 | $31,773 |
| FarxigaDapagliflozin Propanediol | 27 | $29,488 |
| GemtesaVibegron | 28 | $29,359 |
| LinzessLinaclotide | 20 | $22,539 |
| EliquisApixaban | 14 | $21,888 |
| Repatha SureclickEvolocumab | 21 | $18,277 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $5,060 |
| Lidocaine | 28 | $2,976 |
| Atorvastatin Calcium | 314 | $2,691 |
| Duloxetine Hcl | 60 | $2,397 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Forteo, Mounjaro | $656 | $177,79982 claims |
| Boehringer IngelheimJardiance | $38 | $155,548104 claims |
| Novo NordiskOzempic | $1,528 | $138,534105 claims |
| AmgenProlia | $1,088 | $31,77318 claims |
| AstraZenecaFarxiga | $271 | $29,48827 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $196 | $29,35928 claims |
| AbbVieLinzess | $406 | $22,53920 claims |
| PfizerEliquis | $232 | $21,88814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,308 physician assistant providers in Texas.
Other physician assistant in San Antonio
- Anthony DerenciusSan Antonio$507K
- Andrew PrattSan Antonio$87K
- Sarah MerrittSan Antonio$55K
- Monica ChapmanSan Antonio$38K
- Lisa GarrisonSan Antonio$35K
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Brooke HodnickSouthlake$479K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.